Simone Schaefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simone Schaefer has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Iain Alexander Bruce
Department of Paediatric Otolaryngology, Royal Manchester Children’s Hospital, Manchester Foundation Trust, Manchester, UK; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Faculty of Biology, Medicine & Health, Manchester, UK
5 shared publications Iain A. Bruce
Department of Paediatric Otolaryngology, Royal Manchester Children’s Hospital, Manchester University NHS Foundation Trust
2 shared publications- Karolina Kluk
Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, UK
2 shared publications Lise Henderson
Richard Ramsden Centre for Auditory Implants, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
2 shared publicationsA. Metryka
A Paediatric ENT Department , Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester , UK
1 shared publicationAleksandra Metryka
Department of Paediatric Otolaryngology, Royal Manchester Children’s Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom
1 shared publication
Latest Publications
- 4 July 2026
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 27 (4) , 297-307
Aetiology-specific modification of incision design in OSIA® implantation; a cohort of 46 implants in a tertiary paediatric centre
Active transcutaneous bone conduction devices have expanded rehabilitation options for children with conductive, mixed, and single-sided deafness (SSD). The Cochlear™ OSIA® system improves hearing while preserving intact skin. We hypothesised that postoperative outcomes vary by operative context and that incision design may influence complication risk. A prospectively maintained database of paediatric patients implanted between September 2021 and April 2026 was retrospectively analysed. Patients were grouped by operative context: (1) microtia/craniofacial anomalies, (2) surgically altered tissues (chronic ear disease/post-mastoidectomy or conversion from percutaneous devices), and (3) normal anatomy (SSD). The primary outcome was soft tissue complications. Secondary outcomes included audiological improvement and subjective benefit (SAC-A). Thirty-four children underwent 46 OSIA® implants (22 unilateral, 12 bilateral); they were aged between 7-19 years and 56% were female. Seventeen had microtia/craniofacial syndromes, twelve had chronic ear disease (including four conversions), and five had SSD. No perioperative complications occurred. Postoperative soft tissue complications occurred in 4/46 implants (8.7%), exclusively in the microtia/craniofacial and surgically altered tissue groups. One explantation was required for late infection; the remainder were managed conservatively or with revision surgery. Significant improvements were seen at 2 kHz (P = 0.009), 4 kHz (P < 0.001), and in speech recognition (86% to 95%, P = 0.004). SAC-A scores improved significantly (36 to 24; P = 0.002), with 94.1% reporting satisfactory usability. Paediatric OSIA® implantation provides substantial audiological benefit with low complication rates. Complications clustered in anatomically or surgically altered tissues, supporting context-specific counselling and surgical planning.
- 4 July 2026
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 27 (4) , 297-307
Aetiology-specific modification of incision design in OSIA® implantation; a cohort of 46 implants in a tertiary paediatric centre
Active transcutaneous bone conduction devices have expanded rehabilitation options for children with conductive, mixed, and single-sided deafness (SSD). The Cochlear™ OSIA® system improves hearing while preserving intact skin. We hypothesised that postoperative outcomes vary by operative context and that incision design may influence complication risk. A prospectively maintained database of paediatric patients implanted between September 2021 and April 2026 was retrospectively analysed. Patients were grouped by operative context: (1) microtia/craniofacial anomalies, (2) surgically altered tissues (chronic ear disease/post-mastoidectomy or conversion from percutaneous devices), and (3) normal anatomy (SSD). The primary outcome was soft tissue complications. Secondary outcomes included audiological improvement and subjective benefit (SAC-A). Thirty-four children underwent 46 OSIA® implants (22 unilateral, 12 bilateral); they were aged between 7-19 years and 56% were female. Seventeen had microtia/craniofacial syndromes, twelve had chronic ear disease (including four conversions), and five had SSD. No perioperative complications occurred. Postoperative soft tissue complications occurred in 4/46 implants (8.7%), exclusively in the microtia/craniofacial and surgically altered tissue groups. One explantation was required for late infection; the remainder were managed conservatively or with revision surgery. Significant improvements were seen at 2 kHz (P = 0.009), 4 kHz (P < 0.001), and in speech recognition (86% to 95%, P = 0.004). SAC-A scores improved significantly (36 to 24; P = 0.002), with 94.1% reporting satisfactory usability. Paediatric OSIA® implantation provides substantial audiological benefit with low complication rates. Complications clustered in anatomically or surgically altered tissues, supporting context-specific counselling and surgical planning.
- 6 February 2024
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 64 (1) , 51-58
Hearing preservation in paediatric cochlear implantation with the Nucleus Slim Straight Electrode – our experience
Objective: to evaluate the levels of successful hearing preservation and preservation of functional hearing following cochlear implantation (HPCI) in children using the Cochlear Nucleus (R) Slim Straight Electrode (SSE). Design: retrospective case note review of paediatric HPCI cases in our CI centre from 2013 to 2023. Inclusion criteria were attempted hearing preservation surgery, SSE used for implantation, pre-operative hearing thresholds <= 80dBHL at 250 Hz, CI before 18 years of age. Patients were excluded if no postoperative unaided PTA was obtained (poor attendance). Primairy outcome was hearing preservation using the HEARRING group formula; secondary outcome was residual functional hearing (<= 80dBHL at 250 Hz/<90dB LFPTA). Study sample: 56 patients with 94 CI's were included for review. Results: Hearing preservation was achieved in 94.7% (89/94) of ears and complete preservation in 72% (68/94)). Average functional hearing was preserved in 89% using both criteria for preservation. Long-term follow up data was available for 36 ears (average 35.2 months), demonstrating 88.9% (32/36) complete preservation. Conclusion: We have reliably achieved and maintained a high success rate of HPCI using the SSE in our paediatric population. The field of HPCI would benefit from unification of outcome reporting in order to optimise the evidence available to professionals, patients and their carers
- 6 February 2024
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 64 (1) , 51-58
Hearing preservation in paediatric cochlear implantation with the Nucleus Slim Straight Electrode – our experience
Objective: to evaluate the levels of successful hearing preservation and preservation of functional hearing following cochlear implantation (HPCI) in children using the Cochlear Nucleus (R) Slim Straight Electrode (SSE). Design: retrospective case note review of paediatric HPCI cases in our CI centre from 2013 to 2023. Inclusion criteria were attempted hearing preservation surgery, SSE used for implantation, pre-operative hearing thresholds <= 80dBHL at 250 Hz, CI before 18 years of age. Patients were excluded if no postoperative unaided PTA was obtained (poor attendance). Primairy outcome was hearing preservation using the HEARRING group formula; secondary outcome was residual functional hearing (<= 80dBHL at 250 Hz/<90dB LFPTA). Study sample: 56 patients with 94 CI's were included for review. Results: Hearing preservation was achieved in 94.7% (89/94) of ears and complete preservation in 72% (68/94)). Average functional hearing was preserved in 89% using both criteria for preservation. Long-term follow up data was available for 36 ears (average 35.2 months), demonstrating 88.9% (32/36) complete preservation. Conclusion: We have reliably achieved and maintained a high success rate of HPCI using the SSE in our paediatric population. The field of HPCI would benefit from unification of outcome reporting in order to optimise the evidence available to professionals, patients and their carers
- 10 January 2021
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 60 (8) , 561-577
The benefits of preserving residual hearing following cochlear implantation: a systematic review
Systematically review the current literature for evidence on the “real-life” benefits of hearing preservation cochlear implantation (HPCI) for children and adults. Systematic search of Pubmed, MEDL...
- 10 January 2021
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 60 (8) , 561-577
The benefits of preserving residual hearing following cochlear implantation: a systematic review
Systematically review the current literature for evidence on the “real-life” benefits of hearing preservation cochlear implantation (HPCI) for children and adults. Systematic search of Pubmed, MEDL...
- 23 October 2018
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 20 (1) , 39-46
Improved speech and language development after unilateral cochlear implantation in children with a potentially useable contralateral ear
Objectives: Increasingly, children are considered for a unilateral cochlear implant (CI), even if the contralateral ear falls outside current audiological guidelines, especially if they are not considered to be reaching their educational potential. Here we present the outcomes of CI in children with potentially useable hearing in the contralateral ear. Methods: A retrospective case note review was performed for a total of 57 patients. Primary outcome was speech and language (SaL) development, as measured by the Manchester Speech and Language Development Scale (MSLDS) and SaL age equivalent. Secondary outcomes were auditory perception, perceived parental benefit and compliance; respectively measured by Categories of Auditory Performance (CAP), Brief Assessment of Parental Perception (BAPP) and reported use. Results: SaL development improved after CI with a mean pre-operative MSLDS score of 5.8 to a postoperative score of 8.0 (n = 57) and a mean SaL age equivalent of 14 months in a one-year period (n = 14). Furthermore, CAP scores improved from 4.9 to 7.0 (n = 57). Analysis of BAPP scores showed improved quality of life in 18/19 patients (94.7%). With regards to compliance, 50/57 (87.7%) are fulltime users of both their CI and their HA. Conclusion: The present study indicates that despite one ear having potentially useable hearing outside national audiological criteria, the majority of participants received benefit from a CI in the poorer hearing ear. We suggest that assessment of each ear separately and treatment with the most appropriate amplification device, has given these children a benefit they may not otherwise have acquired if they only had bilateral HA.
- 23 October 2018
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 20 (1) , 39-46
Improved speech and language development after unilateral cochlear implantation in children with a potentially useable contralateral ear
Objectives: Increasingly, children are considered for a unilateral cochlear implant (CI), even if the contralateral ear falls outside current audiological guidelines, especially if they are not considered to be reaching their educational potential. Here we present the outcomes of CI in children with potentially useable hearing in the contralateral ear. Methods: A retrospective case note review was performed for a total of 57 patients. Primary outcome was speech and language (SaL) development, as measured by the Manchester Speech and Language Development Scale (MSLDS) and SaL age equivalent. Secondary outcomes were auditory perception, perceived parental benefit and compliance; respectively measured by Categories of Auditory Performance (CAP), Brief Assessment of Parental Perception (BAPP) and reported use. Results: SaL development improved after CI with a mean pre-operative MSLDS score of 5.8 to a postoperative score of 8.0 (n = 57) and a mean SaL age equivalent of 14 months in a one-year period (n = 14). Furthermore, CAP scores improved from 4.9 to 7.0 (n = 57). Analysis of BAPP scores showed improved quality of life in 18/19 patients (94.7%). With regards to compliance, 50/57 (87.7%) are fulltime users of both their CI and their HA. Conclusion: The present study indicates that despite one ear having potentially useable hearing outside national audiological criteria, the majority of participants received benefit from a CI in the poorer hearing ear. We suggest that assessment of each ear separately and treatment with the most appropriate amplification device, has given these children a benefit they may not otherwise have acquired if they only had bilateral HA.
- Open Access
- 18 October 2018
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 20 (1) , 31-38
Cochlear implantation in children with auditory neuropathy: Lessons from Brown–Vialetto–Van Laere syndrome
Objective: Brown–Vialetto–Van Laere syndrome (BVVL) is a rare neurodegenerative disorder associated with auditory neuropathy (AN). The decision process for CI in AN is evolving with increasing evidence of efficacy. We evaluated the benefit of CI in children with BVVL syndrome. Methods: A retrospective study reviewed the pre- and post-operative hearing outcomes of three patients with BVVL who presented for CI. A fourth patient with BVVL who was not suitable for CI is also discussed. The primary outcomes were hearing thresholds and auditory perception. Outcome measurement instruments included visual reinforcement audiometry (VRA) or Play Audiometry (PA), Categories of Auditory Performance (CAP) and Auditory Speech Sound Evaluation (ASSE). Secondary outcomes were parental report (BAPP questionnaire), the perception of our SaLT and compliance. Results: Patient 1 had ASSE levels of 40–45 dB HL 1 year post-operatively, and CAP score had improved from 2 to 5. At 2-year review, aided thresholds were 40 dB at 2–4 kHz. Three months following CI, the CAP score of Patient 2 had improved from 3 to 5. At 6 months, thresholds were 25–30 dB at 2–4 kHz. Single words/phrases are used by both patients and benefit is reported by both families. Patient 3 has recently undergone CI, having been previously rejected at another centre. Three months following CI, his thresholds were 35–40 dB at 2–4 kHz and increased use of sign and vocalization is reported. Conclusion: CI in children with AN complicating BVVL has a variable, but a positive effect. Other manifestations of BVVL make measuring benefit challenging, in the absence of a ‘bespoke’ measurement instrument for children with complex needs. This study provides further evidence for the benefit of CI in children with AN.
- 18 October 2018
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 20 (1) , 31-38
Open AccessCochlear implantation in children with auditory neuropathy: Lessons from Brown–Vialetto–Van Laere syndrome
Objective: Brown–Vialetto–Van Laere syndrome (BVVL) is a rare neurodegenerative disorder associated with auditory neuropathy (AN). The decision process for CI in AN is evolving with increasing evidence of efficacy. We evaluated the benefit of CI in children with BVVL syndrome. Methods: A retrospective study reviewed the pre- and post-operative hearing outcomes of three patients with BVVL who presented for CI. A fourth patient with BVVL who was not suitable for CI is also discussed. The primary outcomes were hearing thresholds and auditory perception. Outcome measurement instruments included visual reinforcement audiometry (VRA) or Play Audiometry (PA), Categories of Auditory Performance (CAP) and Auditory Speech Sound Evaluation (ASSE). Secondary outcomes were parental report (BAPP questionnaire), the perception of our SaLT and compliance. Results: Patient 1 had ASSE levels of 40–45 dB HL 1 year post-operatively, and CAP score had improved from 2 to 5. At 2-year review, aided thresholds were 40 dB at 2–4 kHz. Three months following CI, the CAP score of Patient 2 had improved from 3 to 5. At 6 months, thresholds were 25–30 dB at 2–4 kHz. Single words/phrases are used by both patients and benefit is reported by both families. Patient 3 has recently undergone CI, having been previously rejected at another centre. Three months following CI, his thresholds were 35–40 dB at 2–4 kHz and increased use of sign and vocalization is reported. Conclusion: CI in children with AN complicating BVVL has a variable, but a positive effect. Other manifestations of BVVL make measuring benefit challenging, in the absence of a ‘bespoke’ measurement instrument for children with complex needs. This study provides further evidence for the benefit of CI in children with AN.
- 1 May 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 111, 149-152
Transnasal adenoidectomy in mucopolysaccharidosis
- 1 May 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 111, 149-152
Transnasal adenoidectomy in mucopolysaccharidosis
- Open Access
- 21 July 2017
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 18 (5) , 237-239
Review of outcomes and measurement instruments in cochlear implantation studies
(2017). Review of outcomes and measurement instruments in cochlear implantation studies. Cochlear Implants International: Vol. 18, No. 5, pp. 237-239.
- 21 July 2017
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 18 (5) , 237-239
Open AccessReview of outcomes and measurement instruments in cochlear implantation studies
(2017). Review of outcomes and measurement instruments in cochlear implantation studies. Cochlear Implants International: Vol. 18, No. 5, pp. 237-239.